连接式胰岛素笔帽在血糖控制不佳的1型糖尿病患者中的疗效:一项多中心随机临床试验
这项多中心、开放标签、随机对照试验评估胰岛素笔帽Insulclock对1型糖尿病患者血糖控制、治疗依从性和用户满意度的影响。55例可评估受试者随机分为活性组(n=26)和盲法组(n=29),活性组目标范围内时间增加(5.2% vs -0.8%,P=0.016),平均血糖、血糖管理指标、高于范围时间及高血糖指数降低更明显。结论认为Insulclock系统使用与血糖控制、血糖变异性、高血糖风险和治療依从性改善相关。
要点
- 活性组目标范围内时间增加5.2%,盲法组下降0.8%(P=0.016)。
- 活性组平均血糖、血糖管理指标、高于范围时间和高血糖指数降低更明显。
- 活性组按时胰岛素剂量增加,盲法组减少。
核心结论
- Insulclock系统使用与血糖控制不佳的1型糖尿病患者的血糖控制、血糖变异性、高血糖风险和治療依从性改善相关。
研究设计与样本
- 多中心、开放标签、随机对照试验,包括4周导入期和6周双组阶段,参与者随机分入活性组或盲法组。
- 可评估参与者55例(活性组n=26,盲法组n=29)。
主要发现
- 目标范围内时间增加活性组为5.2%,盲法组为-0.8%(P=0.016)。
- 活性组平均血糖、血糖管理指标、高于范围时间和高血糖指数降低更明显。
- 按时胰岛素剂量活性组增加,盲法组减少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy of the insulin pen cap Insulclock on improving glycemic control, treatment adherence, and user satisfaction in people with type 1 diabetes. RESEARCH DESIGN AND METHODS: This multicenter, open-label, randomized controlled trial comprised a 4-week run-in phase and a 6-week double-arm phase in which participants were randomly assigned into an active or masked mode. RESULTS: Fifty-five participants were evaluable (active group, n = 26, masked group, n = 29). The increase in time in range was higher in the active versus masked group (5.2% vs. -0.8%; P = 0.016). The active group showed a higher reduction in mean glucose, glucose management indicator, time above range, and high blood glucose index. On-time insulin doses increased in the active group and decreased in the masked group. CONCLUSIONS: Insulclock system use was associated with improved glycemic control, glycemic variability, hyperglycemia risk, and treatment adherence in people with uncontrolled type 1 diabetes.
引用
- Gomez-Peralta F, Abreu C, Fernández-Rubio E, et al. Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial. Diabetes Care. 2023. PMID: 36448932. doi:10.2337/dc22-0525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。